Editions   North America | Europe | Magazine

WhatTheyThink

RR Donnelley wins agreement to provide materials to pharma company Eisai

Press release from the issuing company

Chicago - R. R. Donnelley & Sons Company announced today that it has been awarded a multi-year agreement to provide enterprise-wide promotional and marketing collateral materials to Eisai. An on-site RR Donnelley service team will coordinate print production that draws on the company's commercial printing, direct mail, digital printing and other resources.

Eisai Inc. (pronounced a-zi) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care company that discovers, develops and markets products throughout the world.

"Our heritage and mission have earned us recognition as an innovative, efficient, solution-oriented company and we look for those same qualities in our suppliers," said Hans Engel, Purchasing Manager at Eisai. "We found them in RR Donnelley and believe that their comprehensive product line, manufacturing experience and print management resources will deliver exceptional value to Eisai."

"We are very pleased to have the opportunity to support Eisai Inc.," stated John Paloian, RR Donnelley's Chief Operating Officer. "Producing integrated communications, particularly for pharmaceutical and life sciences companies requires exceptional responsiveness, precision and quality. The combination of technology and craftsmanship that we offer across the breadth of our platform is ideally suited to meeting exactly these challenges."

WhatTheyThink is the official show daily media partner of drupa 2024. More info about drupa programs